Cocaine Use Disorders Clinical Trial
Official title:
Human Laboratory Study of the Impact of Buspirone Maintenance on the Reinforcing, Subjective and Performance Effects of Cocaine
Cocaine use disorders are an unrelenting public health concern. Intensive research efforts have yielded behavioral interventions that reduce cocaine use, however, these interventions are not universally effective and treatment effects diminish over time. Development of a pharmacotherapy that enhances the efficacy of these interventions is a priority for the National Institute on Drug Abuse. This study proposes to determine the impact of buspirone maintenance on self-administration of cocaine and alternative reinforcers. These preliminary data will be used to support further research developing buspirone as a pharmacotherapy for cocaine use disorders. We hypothesize that buspirone will attenuate the reinforcing effects of cocaine and increase the reinforcing effects of alternative reinforcers.
n/a
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00759473 -
D-Cycloserine Facilitation of Cocaine - Cue Extinction
|
Phase 2 | |
Completed |
NCT00780442 -
D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals
|
Phase 2 | |
Completed |
NCT00178776 -
A Transtheoretical Model Group Therapy for Cocaine
|
Phase 1 | |
Recruiting |
NCT02680288 -
Lorcaserin Intra Venous Cocaine Effects
|
Phase 1/Phase 2 | |
Completed |
NCT02909101 -
Project IMPACT: Improving Memory Performance by Applying Cognitive Training
|
N/A | |
Completed |
NCT01739192 -
A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
|
Early Phase 1 | |
Completed |
NCT01495195 -
Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
|
Phase 2 | |
Completed |
NCT02373124 -
Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial
|
Phase 1/Phase 2 |